Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cyclezyme ABXSAT:CYCLE +1.44%8 Return-on-Tangible-Asset is -109.62% as of Mar. 2026. GuruFocus rates XSAT:CYCLE with a GF Score™ of 8/100. The stock has 3 warning signs investors should review. Among 1,613 Chemicals companies, Cyclezyme AB ranks worse than 98.02% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Cyclezyme AB's annualizedNet Income for the quarter that ended in Mar. 2026 was kr-3.33 Mil. Cyclezyme AB's average total tangible assets for the quarter that ended in Mar. 2026 was kr3.04 Mil. Therefore, Cyclezyme AB's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was -109.62%.
The historical rank and industry rank for Cyclezyme AB's Return-on-Tangible-Asset or its related term are showing as below:
XSAT:CYCLE'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -95.73 Med: -49.33 Max: -35.12
Current: -70.14
During the past 6 years, Cyclezyme AB's highest Return-on-Tangible-Asset was -35.12%. The lowest was -95.73%. And the median was -49.33%.
XSAT:CYCLE's Return-on-Tangible-Asset is ranked worse than 98.02% of 1613
companies
in the Chemicals industry
Industry Median: 3.13
vs XSAT:CYCLE: -70.14
Cyclezyme AB (XSAT:CYCLE) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Cyclezyme AB Return-on-Tangible-Asset Related Terms
Cyclezyme AB Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Cyclezyme AB's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:CYCLE vs LIN, SHW, ECL: Return-on-Tangible-Asset Comparison
For the Specialty Chemicals subindustry, Cyclezyme AB's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cyclezyme AB Return-on-Tangible-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Cyclezyme AB's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Cyclezyme AB's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of -109.62% mean?
Cyclezyme AB (XSAT:CYCLE) has a Return-on-Tangible-Asset of -109.62% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Cyclezyme AB and its competitors. According to the industry distribution chart, Cyclezyme AB ranks #1581 out of 1613 companies in the Chemicals industry, placing it in the top 98%.
Is Cyclezyme AB's Return-on-Tangible-Asset too high?
Cyclezyme AB's current Return-on-Tangible-Asset is -109.62%. Based on the distribution chart, Cyclezyme AB ranks #1581 out of 1613 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Cyclezyme AB has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Cyclezyme AB's Return-on-Tangible-Asset compare to LIN and SHW?
According to the Chemicals industry distribution chart, Cyclezyme AB ranks #1581 out of 1613 companies for Return-on-Tangible-Asset. This places Cyclezyme AB in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.13. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Chemicals company?
The median Return-on-Tangible-Asset among Chemicals companies is 3.13, based on 1,613 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Cyclezyme AB and its competitors. For the Chemicals industry, the median Return-on-Tangible-Asset is 3.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cyclezyme AB's current Return-on-Tangible-Asset is -109.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyclezyme AB stock overvalued right now?
Cyclezyme AB (XSAT:CYCLE) has a current Return-on-Tangible-Asset of -109.62%. The current Return-on-Tangible-Asset is -109.62%. Cyclezyme AB's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Cyclezyme AB (XSAT:CYCLE), the current Return-on-Tangible-Asset is -109.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.
8GF Score
Get the complete analysis for XSAT:CYCLE
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:CYCLE has been successfully added to your 
